Cubist Pharmaceuticals Inc
Must-know: Why Maverick adds new position in Ashland
Ashland has seen pressure from activist investor JANA Partners, which acquired a stake in the chemical maker in April, 2013, to boost shareholder value.
Elliott Management starts new position in Cubist Pharmaceuticals
Cubist Pharmaceuticals has grown its pipeline via acquisitions. In 2013, it acquired Trius Therapeutics, obtaining rights to tedizolid phosphate.